drugset / Trial / NCT00656006

A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3

NCT00656006

Phase 2 Completed 43 enrolled Human Genome Sciences Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

A Study of Albuferon with Ribavirin in Interferon Alfa Naive Subjects with Chronic Hepatitis C Genotype 2 or 3.

Timeline

Start
2005-11
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Albuferon Protein / enzyme biologic
Subject Ribavirin Small molecule